Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
QUESTLAB

Quest Laboratories Share Price

 

 

Quest Laboratories live price: ₹116.95. It opened at ₹113 vs previous close ₹116; intraday high/low: ₹117/₹113. The 50 & 200 DMA stand at ₹117.53/₹109.17.

Quest Laboratories Performance

  • Today's Low
  • ₹113
  • Today's High
  • ₹117
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹153
  • Open Price₹113
  • Previous Close₹116
  • Volume21,600
  • 50 DMA₹117.53
  • 100 DMA₹113.35
  • 200 DMA₹109.17

Quest Laboratories Chart

Investment Returns

  • Over 1 Month -19.54%
  • Over 3 Month -3.15%
  • Over 6 Month + 34.74%
  • Over 1 Year + 39.64%

Smart Investing Starts Here Start SIP with Quest Laboratories for Steady Growth!

Invest Now

Quest Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.1
  • PEG Ratio
  • -
  • Market Cap Cr
  • 192
  • P/B Ratio
  • 2
  • Average True Range
  • 6.2
  • EPS
  • 8.59
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.82
  • RSI
  • 48.83
  • MFI
  • 20.64

Quest Laboratories Financials

Quest Laboratories Technicals

EMA & SMA

Current Price
₹116.95
+ 0.85 (0.73%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹117.65
  • 50 Day
  • ₹117.53
  • 100 Day
  • ₹113.35
  • 200 Day
  • ₹109.17

Resistance and Support

115.65 Pivot Speed
  • R3 122.30
  • R2 119.65
  • R1 118.30
  • S1 114.30
  • S2 111.65
  • S3 110.30

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Quest Laboratories Ltd has an operating revenue of Rs. 125.87 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 18% is great, ROE of 16% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 12% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -8% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at D- which indicates heavy supply, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Quest Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results
2026-02-13 Quarterly Results
2025-11-13 Quarterly Results & Others To consider other business matters.
2025-05-28 Audited Results
2025-01-27 Others To consider other business matters.

Quest Laboratories Shareholding Pattern

66.78%
0%
0.61%
26.99%
5.62%

Quest Laboratories FAQs

Quest Laboratories share price is ₹116 As on 30 May, 2026 | 15:02

The Market Cap of Quest Laboratories is ₹191.6 Cr As on 30 May, 2026 | 15:02

The P/E ratio of Quest Laboratories is 14.1 As on 30 May, 2026 | 15:02

The PB ratio of Quest Laboratories is 2 As on 30 May, 2026 | 15:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23